MRI-based Nomogram Predicts the Risk of Progression of Unresectable Hepatocellular Carcinoma After Combined Lenvatinib and anti-PD-1 Antibody Therapy
- Resource Type
- Article
- Source
- In
Academic Radiology June 2022 29(6):819-829 - Subject
- Language
- ISSN
- 1076-6332